Zhejiang Garden Biopharmaceutical Co., Ltd. (300401.SZ) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

13.7x

Market Cap

CNY 7.70B

MomentumView details →

1D Return

−8.42%

YTD Return

−2.45%

RSI (14)

49.9

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

13.7x

Market Cap

CNY 7.70B

RSI (14)

49.9

MomentumView details →

1D Return

−8.42%

YTD Return

−2.45%

ProfitabilityView details →

Gross Margin

53.73%

Net Margin

21.77%

EBITDA Margin

44.48%

ROE (TTM)

7.30%

ROA (TTM)

4.30%

Asset Turnover

0.20x

GrowthView details →

Revenue YoY

−4.16%

EPS YoY

−18.64%

FCF YoY

+1696.21%

Revenue CAGR 3Y

−4.43%

EPS CAGR 3Y

−7.17%

EBITDA YoY

—

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

CNY 0.00

Avg Surprise (4Q)

—

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

0.20x

Current Ratio

2.08x

Quick Ratio

1.47x

Div Yield

0.77%

Div Rate

CNY 0.11

Div Growth 1Y

−0.88%

Financials snapshotView financials →

Revenue (TTM)

1.19B

Net Income (TTM)

258.62M

Op. CF (TTM)

530.30M

Latest newsMore news →

Garden Bio disclosed its semi-annual report on August 14, reporting first-half net profit attributable to shareholders of 132 million yuan, down 18.34% year-on-year.23d ago

Garden Bio received a Drug Manufacturing License from Zhejiang Province Medical Products Administration, valid until August 9, 2031, marking its first such license and passing GMP compliance inspection.24d ago

Similar companies

久之洋300516.SZ 壹连科技301631.SZ 盟固利301487.SZ 中集环科301559.SZ 旷达科技002516.SZ 北京科锐002350.SZ Find similar companies →

Latest newsMore news →

Garden Bio disclosed its semi-annual report on August 14, reporting first-half net profit attributable to shareholders of 132 million yuan, down 18.34% year-on-year.23d ago Garden Bio received a Drug Manufacturing License from Zhejiang Province Medical Products Administration, valid until August 9, 2031, marking its first such license and passing GMP compliance inspection.24d ago